Suppr超能文献

抗NC-2单克隆抗体鉴定出小鼠中介导自然细胞毒性的细胞上的第二种受体。

Monoclonal antibody anti-NC-2 identifies a second receptor on cells mediating natural cytotoxicity in mice.

作者信息

Shirzadeh H, Burton R C, Brien J H, Smart Y C

机构信息

Faculty of Medicine and Health Sciences, University of Newcastle, Australia.

出版信息

Immunology. 1998 Jan;93(1):122-8. doi: 10.1046/j.1365-2567.1998.00394.x.

Abstract

We have previously reported the identification by the murine monoclonal antibody (mAb) 1C4 of the first leucocyte receptor which is involved in natural cytotoxicity (NC) against WEHI-164; the NC-1.1 receptor. We report herein the identification and characterization of a second leucocyte receptor which is involved in NC, NC-2 (MW 50,000), identified by a rat anti-mouse mAb D9 (immunoglobulin G2a; IgG2a). Flow cytometric analysis showed that NC-2 was expressed on < 6% of splenic leucocytes of different inbred mouse strains and 96% of the cells of a mast-cell line which has high NC activity. In vitro treatment of splenic leucocytes with the D9 mAb blocked effector cell-WEHI-164 target cell conjugation and NC by approximately 50% without affecting natural killing (NK). Western blot analysis of affinity purified NC-2 and NC-1.1 using the D9 and 1C4 mAbs showed specific reactivity of the proteins with D9 and 1C4, respectively. Pretreatment of splenic leucocytes with both mAbs blocked NC 84%, a result which almost doubled that caused by either mAb alone. Flow cytometric screening of 16 different mouse cell lines showed that 19% of the cell lines expressed both receptors, 6% expressed only NC-2, 44% expressed mainly or only NC-1.1 and the remaining cells expressed neither receptor. These data indicate that D9 identifies a xeno-antigen, NC-2, which is expressed on cells mediating NC and not NK, and that it is not the previously described NC-1.1 allo-antigen. We conclude that NC-2 is likely to be one of a number of receptor molecules on cells mediating NC against tumour cells.

摘要

我们之前曾报道,通过鼠单克隆抗体(mAb)1C4鉴定出首个参与对WEHI-164自然细胞毒性(NC)的白细胞受体,即NC-1.1受体。本文报道了另一种参与NC的白细胞受体NC-2(分子量50,000)的鉴定和特性,它是由大鼠抗小鼠mAb D9(免疫球蛋白G2a;IgG2a)鉴定出来的。流式细胞术分析显示,NC-2在不同近交系小鼠品系的脾白细胞中表达率低于6%,而在具有高NC活性的肥大细胞系的96%细胞中表达。用D9 mAb体外处理脾白细胞可使效应细胞与WEHI-164靶细胞的结合及NC阻断约50%,而不影响自然杀伤(NK)。用D9和1C4 mAb对亲和纯化的NC-2和NC-1.1进行蛋白质印迹分析,结果显示这些蛋白质分别与D9和1C4有特异性反应。用两种mAb预处理脾白细胞可阻断84%的NC,这一结果几乎是单独使用任一mAb所导致结果的两倍。对16种不同小鼠细胞系进行流式细胞术筛选表明,19%的细胞系同时表达这两种受体,6%仅表达NC-2,44%主要或仅表达NC-1.1,其余细胞均不表达这两种受体。这些数据表明,D9识别一种异种抗原NC-2,它在介导NC而非NK的细胞上表达,且不是先前描述的NC-1.1同种抗原。我们得出结论,NC-2可能是介导对肿瘤细胞NC的细胞上多种受体分子之一。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7f5/1364115/7a0db0f98ef9/immunology00045-0133-a.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验